Pharmacokinetics and dynamics Flashcards

1
Q

Define absorbtion

A
  • Transfer of a drug molecule from site of administration to systemic circulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which two types of administration have no barriers?

A

IA
IV
100% dose reaches systemic circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

State three mechanisms for drug permeation across cell membranes

A
  • Passive diffusion through hydrophobic membrane, e.g. lipid soluble
  • Passive diffusion through aqeuous pores, e.g. lithium
  • Carrier mediated transport, e.g. neurotransmitters
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

State two factors affecting drug absorption

A
  • Lipid solubulity
  • Drug ionisation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

State factors of first pass metabolism

A
  • Degradation by enzymes in intestinal wall
  • Absorption from **intestine into hepatic portal vein + metabolism via liver enzymes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define bioavailability

A

Proportion of administered drug which reaches the systemic circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

State factors affecting drug distrubution across compartments

A

Molecule size –> smaller molecule = more distribution
Lipid solubulity –> lipophillic = more distrubtion
Protein binding, e.g. to albumin –> more protein bound = less distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is Vd

A
  • Theoretical volume of drug distrubuted in the body
  • Volume of plasma required to contain the total administered dose
  • Well distributed = high Vd
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

State three ways in which drugs can reach the CNS

A
  • High lipid solubility
  • Intrathecal administration, e.g. baclofen in MS
  • Inflammation (causes barrier to become leaky)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Define drug elimination

A

drug becomes no longer available to effect the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Define metabolism of drugs

A

Modification of chemical structure to form new chemical entity, or metabolite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

State two phases of metabolism

A
  • Oxidation/reduction/hydrolysis to introduce reactive group to chemical structure –> carried out by CYP450 enzymes
  • Conjugation of functional group to produce hydrophilic, inert molecule
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

State the three proceses for renal extraction of drugs

A
  • Glomerular filtration –> free/unbound drug molecules
  • Active tubular secretion –> can clear protein binding drugs + drugs transported by OAT + OCT
  • Passive reabsorption –> highly polar drugs + hydrophobic drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Define the half life of a drug, and what what this is dependant on

A
  • Time taken for plasma drug conc to fall below 50%
  • Dependant on clearance (CL) of drug from body by all eliminating orans
  • Dependant on volume distribution (drug wtih large Vd is cleared more slowly)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In relation to half life, which drugs are more likely to cause withdrawal symptoms?

A
  • Drugs with short half life increases risk of withdrawal symtoms
  • Therefore drugs may need dose weaning on cessation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the equation showing time to Steady state?

A

Css = 5 x t1/2

17
Q

What are drugs with a narrow therapeutic windows? Give Examples

A
  • Drugs with narrow window between MEC and MSC
  • E.g. vancomycin, gentamicin, digoxin, lithium, phenytoin, theophylline
18
Q

What do MSC and MEC stand for

A

MSC - Maximum safe concentration before toxicity
MEC - minimum conc for effective treatment

19
Q

Define Pharmacogenomics

A

using genetic info to tailor pharmaceutical treatment to an individual

20
Q

State an example of genomic variation effecting pharmacodynamics and pharmacokinets

A
  • Variation in drug receptor
    -Variaion in efficacy
    -Increased incidence of adverse drug reactions
21
Q
A